Caren Pharma
Research - Chicago, Illinois, United States
Caren Pharma Employees
Caren Pharma Senior Management
Caren Pharma Details
Caren's Story began with Ed Friedman, PhD (U of Chicago) spending 17+ years as a Theoretical Biologist. Throughout his research, Ed independently analyzed thousands of publications and has become a world-renowned expert on hormone receptors. Ed has since published a book, 14 scientific letters and articles, and spoke at several conferences. His ongoing research has fueled a need to share the curative power of hormones with the world. Ed's son, David Friedman, was working in Investment Banking when he began exploring Ed's scientific model. David recognized that this science (supported by 150+ articles), if further tested and brought to the public, could change the world. Caren was formed in 2019 to make this shared dream a reality. Today, Caren Pharma's first hormone product is in preclinical trials. Caren is seeking FDA-approval for our unique patented formulation for the cessation of Alzheimer's Disease progression. Should you wish to connect or learn more about what Caren is doing, please reach out at www.carenpharma.com/contact-us
Caren Pharma Technologies
Email Providers
Outlook
Load Balancers
Varnish
CMS
Wix
Hosting
Google Cloud Hosting
Other
Mobile Friendly